| Autor: |
Shadman, M., Li, H., Rimsza, L., Leonard, J. P., Kaminski, M. S, Spier, C. M, Gopal, A. K, Dakhil, S., LeBlanc, M., Smith, S. M., Friedberg, J. W |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p116-117, 2p |
| Abstrakt: |
A "FUNCTIONAL CURE" MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15-YEAR FOLLOW-UP OF PHASE III SWOG-S0016 S0016 enrolled patients with untreated advanced FL (bulky stage II or III-IV) between 2001 and 2008 and randomized them to CHOP × 6 followed by (131) I-tositumomab radioimmunotherapy (CHOP-RIT) or CHOP-R × 6; no maintenance was included. B Background: b Follicular lymphoma (FL) is considered incurable with current therapies which include chemoimmunotherapy as the standard of care for first line. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text